Knowledge of antithrombotic prophylaxis among patients with atrial fibrillation

Folia Cardiologica

Volumn 14, Issue 1, 2007, Pages 44-49

  Rewiuk, Krzysztof ^a   Bednarz, Stefan ^a   Faryan, Piotr ^a   Grodzicki, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acenocoumarol; Atrial fibrillation; Patients' knowledge

Indexed keywords

ACENOCOUMAROL; ACENOCUMAROL; ACETYLSALICYLIC ACID; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG INDICATION; EDUCATION; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIMARY PREVENTION; QUESTIONNAIRE; SCORING SYSTEM; SEX; STATISTICAL SIGNIFICANCE; STROKE;

EID: 34247478457     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The AFFIRM Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002; 347: 1825-1833.
2. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med, 1999; 131: 492-501.
3. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J, 2001; 22: 1852-1923.
4. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation (Sixth ACCP consensus conference on antithrombotic therapy). Chest, 2001; 119: 194S-206S.
5. Trusz-Gluza M, Dabrowski A, Kornacewicz-Jach Z et al. Nadkomorowe zaburzenia rytmu serca. Polskie Towarzystwo Kardiologiczne Standardy postepowania w chorobach układu krazenia. Kardiol Pol, 1997; 66 (suppl I): 51-63.
6. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med, 2000; 160: 41-45.
7. Rewiuk K, Bednarz S, Faryan P, Kakol J, Grodzicki T. Rozpowszechnienie i jakość profilaktyki przeciwzakrzepowej u chorych z migotaniem przedsionków. Folia Cardiol, 2003; 10: 633-640.
8. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med, 1997; 157: 978-984.
9. Taylor FC, Ramsay ME, Tan G, Gabbay J, Cohen H. Evaluation of patients' knowledge about anticoagulant treatment. Qual Health Care, 1994; 3: 79-85.
10. Lip GYH, Kamath S, Jafri M, Mohammed A, Bareford D. Ethnic differences in patient perception of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke, 2002; 33: 238-244.
11. Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients' warfarin knowledge and anticoagulation control. Ann Pharmacother, 2003; 37: 34-39.
12. de Felipe Medina R. Level of understanding of patients on anticoagulants at a health centre: relationship of this and monitoring of therapy. Aten Primaria, 2003; 32: 101-105.
13. Roche-Nagle G, Chambers F, Nanra J, Bouchier-Hayes D, Young S. Evaluation of patient knowledge regarding oral anticoagulants. Ir Med J, 2003; 96: 211-213.
14. Saligari E, Belle L, Berry C et al. Evaluation of an education program of patients undergoing anticoagulation treatment. Ann Cardiol Angeiol. 2003; 52: 297-301.
15. Goldsmith I, Turpie AGG, Lip GYH. ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves. BMJ, 2002; 325: 1228-1231.
16. Task Force for the Diagnosis and Treatment of Chronic Heart Failure European Society of Cardiology: Zalecenia Europejskiego Towarzystwa Kardiologicznego. Rozpoznawanie i leczenie przewlekłej niewydolności serca. Folia Cardiol, 2002; 9 (suppl. A): A1-A72.
17. JNC VII Express - VII Report Joint National Committee w sprawie zapobiegania, wykrywania, oceny i leczenia nadciśnienia tetniczego. Folia Cardiol, 2003; 10 (suppl. A): A1-A20.
18. Fihn SD, Williams SV, Daley J, Gibbons RS. Guidelines for the management of patients with stable angina: treatment. Ann Inter Med, 2001; 135: 616-632.
19. Wizner B, Grodzicki T, Gryglewska B, Kocemba J. Wiedza o nadciśnieniu tectniczym i zachowania prozdrowotne mieszkańców Krakowa. Nadciśnienie Tetnicze 1998; 2: 199-206.
20. Ni H, Nauman D, Burgess D, Wise K, Crispell K, Hershberger RE. Factors influencing knowledge of and adherence to self-care among patients with heart failure. Arch Intern Med, 1999; 159: 1613-1619.
21. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med, 1996; 124: 970-979.
22. Arnsten J, Gelfan JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med, 1997; 103:11-17.
23. Braddock CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W. Informed decision making in outpatient practise. Time to get back to basis. JAMA, 1999; 282: 2313-2320.
24. Man-Son-Hing M, Laupacis A, O'Connor AM et al. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation. JAMA, 1999; 282: 737-743.
25. Man-Son-Hing M, Laupacis A, O'Connor A et al. Warfarin for atrial fibrillation: the patient's perspective. Arch Intern Med, 1996; 156: 1841-1848.